Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
about
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaBarrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisRisk factors for neoplastic progression in Barrett's esophagusBOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.The changing face of esophageal cancerIncidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storageThe role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagusMechanisms of obesity-induced gastrointestinal neoplasiaSerum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to ChinaPredictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceA Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's EsophagusDistribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagusThe impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.Predictors of progression in Barrett's esophagus: current knowledge and future directionsThe association between obesity factor and esophageal caner.Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective studyAssociation between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpressionProtective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus.NSAID use and somatic exomic mutations in Barrett's esophagus.
P2860
Q21563424-B6D6883E-F96D-4A9F-8BA6-7B57C11FCFF7Q24602426-FC190AF4-3807-43A1-940C-0D761D0692A1Q27002062-146836CB-DCC1-4C88-97F9-0B6D0B81437FQ27332349-A2FFD70C-C12D-4D75-B317-654E910AF4D0Q28391577-9FEE5943-C6B2-4A57-881A-A0BB70E7D093Q31044821-F3B2D9B0-7AB4-4A8C-807C-04117772DC65Q34213725-9F6B5A32-5724-4904-8D50-73B05D19FFACQ34542075-3E7CF438-0F30-4635-906F-29353AF10A7AQ35062195-C26C5B40-5ABC-43C4-9C77-2BDB3D0DAD5CQ35073431-CEAAD0B7-AC6A-4E79-99CD-AC6E06649894Q35151103-7B0A3EBE-D59D-4D26-926D-808CE2C5C272Q35666515-F29834B7-B24C-442D-B43A-C667FC242007Q35768888-D94C7994-F900-4517-8D52-596029F563B7Q36014804-CD84599B-C3F3-4B9A-A23A-32E6312A069FQ36055100-B4C423A8-2EC4-4E78-9390-497FCEF2AA24Q36057779-C8B1B318-86FC-40DA-A0B1-1267498385FFQ36127891-597BAD39-84D6-472E-B6E7-DE7DCE9E7EF0Q36162512-A6B06949-26EE-400B-AEEB-D2BFBB42EBA9Q36172769-47960A6C-7D10-4D5B-A605-D92ED8059F46Q36629369-BE1DF3B6-217F-401A-B59D-9E471C04AD61Q37042894-19DB1137-3C71-40CC-B9B4-4FF141072513Q37163349-91D6608E-8DA5-4228-BDCB-C4556FED6153Q37305467-25A9FE7B-F09F-4E31-B0A6-30ADA2D9E88EQ48504657-31EFB15C-0E19-4E9F-96BB-87E3373D7C57Q51746842-0E44A072-2E5E-4C73-8672-48F6DAB93AB0
P2860
Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Nonsteroidal anti-inflammatory ...... lities in Barrett's esophagus.
@en
Nonsteroidal anti-inflammatory ...... lities in Barrett's esophagus.
@nl
type
label
Nonsteroidal anti-inflammatory ...... lities in Barrett's esophagus.
@en
Nonsteroidal anti-inflammatory ...... lities in Barrett's esophagus.
@nl
prefLabel
Nonsteroidal anti-inflammatory ...... lities in Barrett's esophagus.
@en
Nonsteroidal anti-inflammatory ...... lities in Barrett's esophagus.
@nl
P2093
P1476
Nonsteroidal anti-inflammatory ...... alities in Barrett's esophagus
@en
P2093
Alan R Kristal
Brian J Reid
Carissa A Sanchez
Douglas S Levine
Laura J Prevo
Patricia C Galipeau
Thomas L Vaughan
P304
P577
2002-08-01T00:00:00Z